In cancer cells and in aging C. elegans, KLHL22 promotes mTORC1 activation by degrading DEPDC5 and releasing inhibition of GATOR1 on mTORC1 (Fig. S4A) (Chen et al., 2018). Here, KLHL22 is linked to cancer.